Medication info
Grifin Tablets (Pioglitazone Hydrochloride)

Grifin Tablets (Pioglitazone Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Pioglitazone Hydrochloride›16.53mg / 1 tablet
Manufacturer / importer
Samik Pharmaceutical Co., Ltd.
Appearance
White, round tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200708367 · Approved 2007.07.20 · Insurance code 644000040

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
This medication is administered orally once daily, with or without food. For monotherapy, start with 15 mg once daily; if the effect is insufficient, the dose may be increased to 30 mg once daily. For combination therapy, administer 15 mg once daily; the maximum recommended dose should not exceed 30 mg once daily.
Child dose
Use is not recommended in children younger than 18 years because there is no experience with use in this age group.

Ingredients

Manufacturer
Samik Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medication is used in conjunction with dietary therapy and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be used as monotherapy and may be combined with sulfonylureas, metformin, or insulin if there is no improvement in blood sugar with the use of other oral hypoglycemic agents. Additionally, nutrition counseling, weight loss, and regular exercise are important for patients with type 2 diabetes, and these efforts are essential to maintain the effectiveness of drug therapy. This medication is used to improve blood sugar control.

How to take

Adult dose

This medication is administered orally once daily, with or without food. For monotherapy, start with 15 mg once daily; if the effect is insufficient, the dose may be increased to 30 mg once daily. For combination therapy, administer 15 mg once daily; the maximum recommended dose should not exceed 30 mg once daily.

Child dose

Use is not recommended in children younger than 18 years because there is no experience with use in this age group.

Precautions

This medication is used for the treatment of type 2 diabetes and requires the presence of insulin to be effective. This medication may cause or worsen heart failure; therefore, it should not be used in patients with heart failure. After starting treatment or increasing the dose, careful observation for symptoms of heart failure, such as weight changes, shortness of breath, and edema, is necessary. If symptoms of heart failure occur, immediate medical attention should be sought, and if necessary, the administration of this medication can be reduced or discontinued. Furthermore, this medicine can cause fluid retention, which may induce or exacerbate heart failure, so it should be used cautiously in patients with edema or heart diseases. Patients with active bladder cancer or a history of bladder cancer, liver diseases, severe kidney diseases, or diabetic ketoacidosis should not use this medication. Women who are pregnant or may become pregnant should not take this medication, and premenopausal women may require appropriate contraception due to the possibility of ovulation stimulation while taking this medicine. Regular monitoring of blood sugar and liver function tests is required during treatment with this medication, and immediate consultation with a physician should be sought if abnormal symptoms occur. This medication has a risk of hypoglycemia when used in combination with other hypoglycemic agents, so caution regarding dosage adjustment is necessary. Additionally, this medication may cause weight gain and edema, thus careful monitoring of weight changes is essential. In clinical trials and post-marketing surveys, rare side effects such as liver failure, macular edema, and fractures have been reported, so if any related symptoms occur, immediate notification to healthcare providers is necessary. This medication has drug interactions; therefore, it is crucial to inform healthcare providers if other medications are being taken, especially when used with CYP2C8 inhibitors or inducers. In case of overdose, there is no specific antidote, and symptomatic supportive care is needed. Store this medication out of reach of children and keep it in the original container. This medication has not been established for safety and efficacy in children under 18 years old, and caution is advised in patients aged 75 and older.

Side effects

Congestive heart failure, excessive and rapid weight changes, shortness of breath, edema, fluid retention, inadequate blood sugar control, upper respiratory tract infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, diarrhea, elevated blood creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular factors, hospitalization due to worsening congestive heart failure, emergency room visit due to congestive heart failure, cardiovascular adverse events, increased blood sugar, ALT/AST elevation, loss of appetite, constipation, upper abdominal pain, chest discomfort, fatigue, weakness, dyspepsia, nausea, shortness of breath, itching, chest discomfort, trembling, chills, gastrointestinal disorders, abdominal pain, epigastric discomfort, numbness, muscle stiffness, discomfort in the head, increased liver enzymes, worsening of liver disease, urticaria, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, increased blood creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, heart failure, adverse reactions related to edema, liver failure, macular edema, fractures

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is best to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. This way, the medication's effectiveness and safety can be preserved for a long time.

Appearance and packaging

Appearance

White, round tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.